Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.
Rapid-acting psychotropic drugs produce effects within hours rather than weeks, and that speed breaks the trial designs psychiatry has spent decades refining. Blinding is harder. The comparison is harder. What happens after the effect wears off is barely studied.
This notice funds work on those problems directly. The stated purpose is to elucidate the key components of the therapeutic effects of …
Clinical trials addressing the methodological challenges of testing rapid-acting psychotropic interventional drugs, elucidating the components of their therapeutic effects, and studying how these drugs and adjunctive psychosocial interventions are optimally delivered, monitored and sustained over time to improve effectiveness and generalisability. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up